Why Muscle, Our Neglected Organ, Is The Key To Healthy Aging with Dr. Chris Rinsch and Dr. Stuart Phillips

<p>Why Muscle, Our Neglected Organ, Is The Key To Healthy Aging | This episode is brought to you by <a href="https://paleovalley.com/hyman" rel="noopener noreferrer" target="_blank">Paleovalley</a></p><br><p>When it comes to longevity, the goal isn’t just to live as long as possible. The true objective is to live as vibrantly and energetically as possible, for as long as possible. So how exactly do we do this?</p><br><p>On this episode of <em>The Doctor’s Farmacy</em>, I was happy to sit down and talk with Dr. Chris Rinsch and Dr. Stuart Phillips about the role of mitochondria in aging, and how we can use various compounds that are found in plants to upregulate our biology and increase not just our lifespan, but more importantly our healthspan.</p><br><p>Dr. Chris Rinsch is the co-founder and CEO of Amazentis, an innovative life science company dedicated to employing breakthrough research and clinical science to bring advanced therapeutic nutrition products to life. Dr. Rinsch has authored original publications in leading scientific journals, including <em>Nature Medicine</em>,<em> Gene Therapy </em>and others, for his research on Urolithin A, mitochondrial health, and cell and gene therapy. He is also an inventor on a number of internationally filed and granted patents. Dr. Rinsch holds an MBA from INSEAD, France, a PhD in Cell and Molecular Biology from the University of Lausanne, a Master of Science in Biomedical Engineering from U.T. Southwestern Medical Center, and a Bachelor of Science in Engineering from Harvey Mudd College.</p><p>&nbsp;</p><p>Dr. Stuart Phillips is a Professor in the Department of Kinesiology and a member of the School of Medicine at McMaster University. He is Tier 1 Canada Research Chair in Skeletal Muscle Health. He is also the Director of the McMaster University Physical Activity Centre of Excellence. Dr. Phillips has authored more than 220 original research papers and 90 reviews. In 2018 and 2019, he was named to Clarivate’s Highly Cited Researchers list as a being in the top 1% of al